Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Supplement labeling

This article was originally published in The Tan Sheet

Executive Summary

Inspector General's Boston office evaluating effectiveness of FDA's supplement labeling oversight and usefulness of product claims/disclaimers for elderly users of supplements and health professionals advising elderly patients. Report should be available in draft form by year end and is slated for final release early in 2002, OIG says. Research is part of HHS division's follow-up to April 19 report on CFSAN's supplement AER system (1"The Tan Sheet" April 23, pp. 3-6)

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts